跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AS-23
首页
药物
AS-23
AS-23
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
AMIDE-SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN-ALPHA
EP 2922846 B1
申请人: BRISTOL MYERS SQUIBB CO
优先权: 2012
CN
EP
US
WO
16 件公开
Antagonists to IL-17A, IL-17F, and IL-23P19 and methods of use
US 7910703 B2
申请人: ZYMOGENETICS INC
优先权: 2008
US
12 件公开
HUMAN IL-23 ANTIGEN BINDING PROTEINS
EP 3181586 A1
申请人: AMGEN INC
优先权: 2009
CN
EP
US
10 件公开
EMM-23 MOLECULAR SIEVE MATERIAL, ITS SYNTHESIS AND USE
EP 2739567 A1
申请人: EXXONMOBIL CHEM PATENTS INC
优先权: 2011
CN
EP
US
WO
7 件公开
Anti-human interleukin 23 monoclonal antibody and application thereof
US 12692303 B1
申请人: QYUNS THERAPEUTICS CO LTD
优先权: 2020
CN
EP
US
WO
5 件公开
METHODS OF TREATING INFLAMMATORY DISEASES
EP 3560956 A3
申请人: BOEHRINGER INGELHEIM INT
优先权: 2016
EP
US
5 件公开
NEW PEPTIDES AS SELECTIVE IL-23 RECEPTOR INHIBITORS
US 20260250322 A1
申请人: SANOFI
优先权: 2023
CN
EP
US
WO
4 件公开
WO 2025051912 A1
申请人: SANOFI SA
优先权: 2023
CN
WO
2 件公开
Use of 23-hydroxy betutic acid in preparing medicine for treating and preventing tumour and AIDS
CN 1491651 A
申请人: YE WENCAI
优先权: 2003
CN
4 件公开
Truncated keratinocyte growth factor (KGF) having increased biological activity
US 7084119 B2
申请人: CHIRON CORP
优先权: 2003
US
4 件公开
US 2009093400 A1
申请人: NOVARTIS VACCINES & DIAGNOSTIC
优先权: 2000
US
2 件公开
COMPOSITIONS OF ANTI-INTERLEUKIN 12/INTERLEUKIN 23 ANTIBODY
EP 4608862 A1
申请人: AMGEN INC
优先权: 2022
EP
US
WO
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈